Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInvestment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueShares Outstanding (Weighted Average)Tax Rate
Others
Ratios

NewGenIvf (NIVF) EPS (Basic): 2021-2024

Historic EPS (Basic) for NewGenIvf (NIVF) over the last 4 years, with FY2024 value amounting to -$1.32.

  • NewGenIvf's EPS (Basic) rose 72145.39% to $0.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.0, marking a year-over-year increase of 72145.39%. This contributed to the annual value of -$1.32 for FY2024, which is 13739.38% down from last year.
  • NewGenIvf's EPS (Basic) amounted to -$1.32 in FY2024, which was down 13739.38% from $3.53 recorded in FY2023.
  • In the past 5 years, NewGenIvf's EPS (Basic) registered a high of $4.72 during FY2022, and its lowest value of -$1.32 during FY2024.
  • For the 4-year period, NewGenIvf's EPS (Basic) averaged around $1.67, with its median value being $1.64 (2021).
  • In the last 5 years, NewGenIvf's EPS (Basic) surged by 200800.68% in 2022 and then crashed by 13739.38% in 2024.
  • Annual analysis of 4 years shows NewGenIvf's EPS (Basic) stood at -$0.25 in 2021, then soared by 2008.01% to $4.72 in 2022, then fell by 25.21% to $3.53 in 2023, then crashed by 137.39% to -$1.32 in 2024.
  • Its last three reported values are -$1.32 in FY2024, $3.53 for FY2023, and $4.72 during FY2022.